arrow
S

Sara Gutiérrez-Enríquez

Helmholtz Association
H指数:33
被引数:4,054

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RNA splicing evidence enables robust classification of BRCA1 exon 18 variants: Results from the ENIGMA consortium

RNA剪接证据能够实现BRCA1外显子18变异的稳健分类:ENIGMA联盟的研究结果

2026-09-010
PRE
Technical note: reconstructing dose distributions from manually planned electron boosts in breast radiotherapy

技术说明:乳腺癌放射治疗中手动计划电子束推量重建剂量分布

2026-08-010
OAAI
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients

前列腺癌患者放疗后2年内疲劳的遗传决定因素

2026-04-220
OAAI
Breast composition and dose deposition to fat and fibroglandular tissues are associated with breast side effects after radiation therapy
2026-01-070
OAAI
Unveiling regions associated with acute and late breast side-effects from breast radiotherapy using voxel-wise image-based data mining analysis

通过体素级图像基于数据挖掘分析揭示与急性及晚期乳腺癌放疗相关的不良反应区域

2025-10-250
PRE
Optimising inter-patient image registration for image-based data mining in breast radiotherapy
2024-10-010
OAAI
CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods

CAGI,基因组解释的关键评估,建立了计算遗传变异解释方法的进展和前景

2024-02-2210
OAAI
A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical Analysis
2024-01-013
OAAI
Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy
BREAST
IF7.9
2023-12-012
OAAI
Reply to: Comments on (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
2023-10-310
PRE
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

大规模的全基因组关联研究揭示了与癌症类型中辐射诱导的急性毒性相关的常见遗传因素

2023-10-203
OAAI
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

乳腺癌放疗后两年治疗相关毒性的全基因组关联研究

2023-10-012
OAAI
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
2023-07-059
OA
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
2022-11-017
OAAI
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
2022-10-018
OAAI
Prevalence of functional and genomic homologous recombination deficiency (HRD) in germline RAD51C/D patients
2022-05-010
OAAI
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

用于鉴定同源重组缺陷肿瘤和患者分层的RAD51测试的临床前体内验证

2022-02-1645
OA